Publication | Open Access

SLV313 (1-(2,3-Dihydro-Benzo[1,4]Dioxin-5-yl)-4- [5-(4-Fluoro-Phenyl)-Pyridin-3-ylmethyl]-Piperazine Monohydrochloride): A Novel Dopamine D2 Receptor Antagonist and 5-HT1A Receptor Agonist Potential Antipsychotic Drug

Psychoactive DrugPsychiatryMedicinePsychopharmacologySchizophreniaNeuropharmacology-Piperazine MonohydrochlorideNeuroscienceBiological PsychiatryDopaminePharmacologySocial SciencesDrug Discovery